Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion
Abstract Objective Understanding the price components of the mifepristone/misoprostol (combi-pack) for medical abortion to improve access is critical for identifying strategies to reduce product costs for quality-assured formulations and expanding its availability and use. Methods We constructed a c...
Saved in:
Main Authors: | Lester Chinery (Author), Chadia Allaouidine (Author), Alessandra Tomazzini (Author), Melanie Larson (Author), A. Metin Gülmezoglu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of Mifepristone and Sublingual Misoprostol for Early Medical Abortion
by: Mau Lin, et al.
Published: (2006) -
Concurrent Use of Mifepristone and Misoprostol for Early Medical Abortion
by: Yiu-Tai Li, et al.
Published: (2006) -
Mifepristone and Misoprostol Induced Abortion with A Large Myomatous Uterus
by: Yiu-Tai Li, et al.
Published: (2005) -
Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
by: Ellen R Wiebe, et al.
Published: (2020) -
Partial Hydatidiform Mole in a Medical Abortion with the Mifepristone/Misoprostol Combination
by: Pui-Ki Chow, et al.
Published: (2004)